IRADIMED CORPORATION (IRADIMED) develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, non-ferrous part and other features in order to deliver anesthesia and other IV fluids during various MRI procedures. MRI compatible IV infusion pump system includes the 3860+ MRI compatible IV infusion pump, single-use IV tubing sets, a non-magnetic pole and a lithium battery. In addition, it offers optional upgrade systems, including the 3865 Remote Display/Control, 3861 Side Car, Dose Error Reduction System (DERS) and SpO2 monitor.
Winter Springs, US
Size (employees)
68 (est)
IRadimed is headquartered in Winter Springs, US

IRadimed Office Locations

IRadimed has an office in Winter Springs
Winter Springs, US (HQ)
1025 Willa Springs Dr

IRadimed Metrics

IRadimed Financial Metrics

IRadimed's revenue was reported to be $32.5 m in FY, 2016 which is a 3% increase from the previous period.

Revenue (FY, 2016)

$32.5 m

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

$26.3 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

$7.2 m

EBIT (FY, 2016)

$10.9 m

Market capitalization (19-May-2017)

$90.8 m

Closing share price (19-May-2017)


Cash (31-Dec-2016)

$17.7 m
IRadimed's current market capitalization is $90.8 m.
FY, 2014FY, 2015FY, 2016


$15.7 m$31.6 m$32.5 m

Revenue growth, %


Cost of goods sold

$3.4 m$5.8 m$6.2 m

Gross profit

$12.2 m$25.8 m$26.3 m

Gross profit Margin, %


Sales and marketing expense

$3.3 m$4.7 m$5.3 m

R&D expense

$1.1 m$1.8 m$1.3 m

General and administrative expense

$4.8 m$7.8 m$8.8 m

Operating expense total

$9.2 m$14.2 m$15.4 m


$3.1 m$11.5 m$10.9 m

EBIT margin, %


Pre tax profit

$967 k$11.6 m$11 m

Income tax expense

$967 k$4.1 m$3.7 m

Net Income

$2.1 m$7.5 m$7.2 m
FY, 2014FY, 2015FY, 2016


$9.5 m$19.4 m$17.7 m

Accounts Receivable

$2 m$3.9 m$3.8 m


$276.5 k$318 k$362.9 k

Current Assets

$22.2 m$34 m$34.2 m


$794.8 k$905.6 k$1.5 m

Total Assets

$23.3 m$35.2 m$37.2 m

Accounts Payable

$629.2 k$1 m$1.1 m

Current Liabilities

$2.3 m$2.9 m$3.7 m

Additional Paid-in Capital

$15.8 m$19.3 m$12.1 m

Retained Earnings

$5.1 m$12.7 m$19.9 m

Total Equity

$20.9 m$31.9 m$31.9 m

Financial Leverage

1.1 x1.1 x1.2 x
FY, 2014FY, 2015FY, 2016

Net Income

$2.1 m$7.5 m$7.2 m

Depreciation and Amortization

$149.1 k$223.9 k$248.3 k

Accounts Receivable

$21.9 k($1.9 m)$75.3 k


($154.9 k)($32 k)$4.9 k

Accounts Payable

$201.7 k$376.3 k$1.1 k

Cash From Operating Activities

$2.6 m$7.6 m$9.4 m

Purchases of PP&E

($584 k)($298.7 k)($780.8 k)

Cash From Investing Activities

($8.3 m)($61.5 k)($1.9 m)

Cash From Financing Activities

$12.7 m$2.3 m($9.1 m)

Income Taxes Paid

$1.2 m$2.7 m$3.4 m
Y, 2016


$477.9 k

Financial Leverage

1.2 x

IRadimed Operating Metrics

FY, 2016

Patents Issued


IRadimed Market Value History

IRadimed Revenue Breakdown

IRadimed Online Presence

IRadimed Company Life

You may also be interested in